Literature DB >> 21425185

Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus Neuropathy?

Mercedes Garces-Sanchez1, Ruple S Laughlin, Peter J Dyck, JaNean K Engelstad, Jane E Norell, P James B Dyck.   

Abstract

OBJECTIVE: Occasionally, diabetic patients develop painless, lower-limb, motor predominant neuropathy. Whether this is a variant of diabetic lumbosacral radiculoplexus neuropathy (DLRPN) (a painful disorder from ischemic injury and microvasculitis), a variant of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) or another disorder is unsettled. Here, we characterize the clinical and pathological features of painless diabetic motor predominant neuropathy.
METHODS: We identified patients with this syndrome who underwent nerve biopsy. We compared pathological features to 33 DLRPN and 25 CIDP biopsies.
RESULTS: 23 patients were identified (22 had type 2 diabetes mellitus); 12 men; median age 62.2 years (range 36-78); median weight loss 30 pounds (range 0-100). Overall, the clinical features were similar to DLRPN except painless patients had more symmetrical and upper limb involvement, with slower progression and more severe impairment. Physiological testing demonstrated pan-modality sensory loss, autonomic abnormalities and axonal polyradiculoneuropathies. Nerve biopsies were similar to DLPRN showing ischemic injury (multifocal fiber loss [11/23], perineural thickening [18/23], injury neuroma [11/23], neovascularization [17/23]) and evidence of altered immunity and microvasculitis (epineurial perivascular inflammation [23/23], prior bleeding [11/23], vessel wall inflammation [15/23], and microvasculitis [3/23]). In contrast, CIDP biopsies did not show ischemic injury or microvasculitis but revealed demyelination and onion-bulbs.
INTERPRETATION: 1) Painless diabetic motor neuropathy is painless DLRPN and not CIDP and is caused by ischemic injury and microvasculitis. 2) The clinical features of painless DLRPN are different from typical DLPRN being more insidious and symmetrical with slower evolution. 3) The slower evolution may explain the lack of pain.
Copyright © 2010 American Neurological Association.

Entities:  

Mesh:

Year:  2011        PMID: 21425185      PMCID: PMC3117939          DOI: 10.1002/ana.22334

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  37 in total

1.  Chronic inflammatory polyradiculoneuropathy.

Authors:  P J Dyck; A C Lais; M Ohta; J A Bastron; H Okazaki; R V Groover
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

2.  Diabetic amyotrophy.

Authors:  H GARLAND
Journal:  Br Med J       Date:  1955-11-26

3.  The syndrome of diabetic amyotrophy.

Authors:  S Chokroverty; M G Reyes; F A Rubino; H Tonaki
Journal:  Ann Neurol       Date:  1977-09       Impact factor: 10.422

4.  Diabetic polyradiculopathy: clinical and electromyographic findings in 105 patients.

Authors:  J A Bastron; J E Thomas
Journal:  Mayo Clin Proc       Date:  1981-12       Impact factor: 7.616

5.  Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.

Authors:  Rizwan U Haq; William W Pendlebury; Timothy J Fries; Rup Tandan
Journal:  Muscle Nerve       Date:  2003-04       Impact factor: 3.217

Review 6.  Diabetic amyotrophy: current concepts.

Authors:  H W Sander; S Chokroverty
Journal:  Semin Neurol       Date:  1996-06       Impact factor: 3.420

7.  Inflammatory vasculopathy in multifocal diabetic neuropathy.

Authors:  Gérard Said; Catherine Lacroix; Pierre Lozeron; Angèle Ropert; Violaine Planté; David Adams
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

8.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.

Authors:  P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

9.  The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later.

Authors:  R J Barohn; Z Sahenk; J R Warmolts; J R Mendell
Journal:  Arch Neurol       Date:  1991-11

10.  Cool, warm, and heat-pain detection thresholds: testing methods and inferences about anatomic distribution of receptors.

Authors:  P J Dyck; I Zimmerman; D A Gillen; D Johnson; J L Karnes; P C O'Brien
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

View more
  8 in total

Review 1.  Diabetic neuropathy: mechanisms, emerging treatments, and subtypes.

Authors:  James W Albers; Rodica Pop-Busui
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

2.  Nosology of idiopathic phrenic neuropathies.

Authors:  Simon Podnar
Journal:  J Neurol       Date:  2014-12-06       Impact factor: 4.849

Review 3.  Immunotherapy for diabetic amyotrophy.

Authors:  Yee Cheun Chan; Yew Long Lo; Edwin Sy Chan
Journal:  Cochrane Database Syst Rev       Date:  2017-07-26

4.  Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  J J Figueroa; P J B Dyck; R S Laughlin; J A Mercado; R Massie; P Sandroni; P J Dyck; P A Low
Journal:  Neurology       Date:  2012-02-22       Impact factor: 9.910

5.  Vasculitic Neuropathies.

Authors:  Elie Naddaf; P James Bonham Dyck
Journal:  Curr Treat Options Neurol       Date:  2015-10       Impact factor: 3.598

6.  Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus.

Authors:  Peng Soon Ng; Peter J Dyck; Ruple S Laughlin; Prabin Thapa; Marcus V Pinto; P James B Dyck
Journal:  Neurology       Date:  2019-02-13       Impact factor: 11.800

7.  Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.

Authors:  Alon Abraham; Majed Alabdali; Mohammad Qrimli; Hana Albulaihe; Ari Breiner; Carolina Barnett; Hans D Katzberg; Leif E Lovblom; Bruce A Perkins; Vera Bril
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

Review 8.  The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.

Authors:  Vera Bril; Christopher M Blanchette; Joshua M Noone; M Chris Runken; Deborah Gelinas; James W Russell
Journal:  J Diabetes Complications       Date:  2016-05-10       Impact factor: 2.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.